Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors

Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors

<p>Abstract</p> <p>Background</p> <p>Aberrant promoter hypermethylation of cancer-associated genes occurs frequently during carcinogenesis and may serve as a cancer biomarker. In this study we aimed at defining a quantitative gene promoter methylation panel that might i...

Full description

Bibliographic Details
Main Authors:	Oliveira Jorge, Pinto Mafalda, Ribeiro Franclim R, Henrique Rui, Costa Vera L, Lobo Francisco, Teixeira Manuel R, Jerónimo Carmen
Format:	Article
Language:	English
Published:	BMC 2007-07-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/7/133

Similar Items

TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions
by: Nuno Cerveira, et al.
Published: (2006-10-01)

Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel
by: Ana Sílvia Pires-Luís, et al.
Published: (2017-06-01)

Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
by: José Pedro Sequeira, et al.
Published: (2021-10-01)

Promoter methylation and large intragenic rearrangements of <it>DPYD </it>are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients
by: Savva-Bordalo Joana, et al.
Published: (2010-09-01)

DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
by: Nuno Tiago Tavares, et al.
Published: (2022-06-01)

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors
by: João Lobo, et al.
Published: (2021-04-01)

DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis
by: Sofia Salta, et al.
Published: (2023-08-01)

DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
by: Vera Constâncio, et al.
Published: (2020-03-01)

Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.
by: Megan L Durr, et al.
Published: (2010-05-01)

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples
by: Rocha Ana, et al.
Published: (2008-12-01)

Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
by: João Ramalho-Carvalho, et al.
Published: (2017-02-01)

Molecular Subtyping of Primary Prostate Cancer Reveals Specific and Shared Target Genes of Different ETS Rearrangements
by: Paula Paulo, et al.
Published: (2012-07-01)

<it>MGMT </it>promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
by: Håvik Annette, et al.
Published: (2012-03-01)

DNA Methylation as a Therapeutic Target for Bladder Cancer
by: Sandra P. Nunes, et al.
Published: (2020-08-01)

Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
by: Anabela Couto-Cunha, et al.
Published: (2022-12-01)

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
by: João Lobo, et al.
Published: (2020-06-01)

The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
by: João Lobo, et al.
Published: (2018-12-01)

Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes
by: Catarina Guimarães-Teixeira, et al.
Published: (2021-09-01)

Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier
by: Kheradpour Albert, et al.
Published: (2008-05-01)

Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation
by: Vera Miranda-Gonçalves, et al.
Published: (2020-04-01)

Recurrence in oral and pharyngeal cancer is associated with quantitative <it>MGMT </it>promoter methylation
by: Chen Jiangying, et al.
Published: (2009-10-01)

DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
by: Catarina Macedo‐Silva, et al.
Published: (2023-04-01)

Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of ‘epidrugs’
by: Ana Rita Cardoso, et al.
Published: (2021-04-01)

Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions
by: João Lobo, et al.
Published: (2021-03-01)

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
by: Bianca C. T. Flores, et al.
Published: (2021-08-01)

LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma
by: José Pedro Sequeira, et al.
Published: (2022-02-01)

Site-specific analysis of ribosomal 2′O-methylation by quantitative reverse transcription PCR under low deoxynucleotide triphosphate concentrations
by: Daniela Barros-Silva, et al.
Published: (2023-05-01)

Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs
by: Gonçalo Outeiro-Pinho, et al.
Published: (2020-08-01)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
by: Vera Miranda-Gonçalves, et al.
Published: (2019-09-01)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
by: Vera Miranda-Gonçalves, et al.
Published: (2018-10-01)

Lower p66Shc promoter methylation in subjects with chronic renal failure.
by: Radhia Hamdi, et al.
Published: (2021-01-01)

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
by: David S Shames, et al.
Published: (2006-12-01)

Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach
by: Filipa Amaro, et al.
Published: (2020-04-01)

DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients
by: José Pedro Sequeira, et al.
Published: (2022-06-01)

Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma
by: Filipa Amaro, et al.
Published: (2022-04-01)

Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
by: Alaa Tahoon, et al.
Published: (2022-02-01)

Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.
by: Victoria Gonzalo, et al.
Published: (2010-01-01)

From Therapy Resistance to Targeted Therapies in Prostate Cancer
by: Filipa Moreira-Silva, et al.
Published: (2022-05-01)

ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis
by: Yanfang Zhao, et al.
Published: (2023-06-01)

The effects of promoter methylation on downregulation of DAZAP2 in multiple myeloma cell lines.
by: Sai-Qun Luo, et al.
Published: (2012-01-01)